| 1 |
Buck ML.Dexmedetomidine use in pediatric intensive care and procedural sedation[J]. J Pediatr Pharmacol Ther, 2010, 15(1): 17-29.
|
| 2 |
Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care[J]. Rev Bras Anestesiol, 2012, 62(1): 118-133.
|
| 3 |
Panzer O, Moitra V, Sladen RN.Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral Mu antagonists[J]. Anesthesiol Clin, 2011, 29(4): 587-605.
|
| 4 |
Afsani N. Clinical application of dexmedetomidine[J]. S Afr J Anaesthesiol Analg, 2010, 16(2): 50-56.
|
| 5 |
Gertler R, Brown HC, Mitchell DH, et al.Dexmedetomidine: a novel sedative-analgesic agent[J]. Proc (Bayl Univ Med Cent), 2001, 14(1): 13-21.
|
| 6 |
Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications[J]. Curr Opin Anaesthesiol, 2008, 21(4): 457-461.
|
| 7 |
Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists[J]. Anesthesiology, 2000, 93(5): 1345-1349.
|
| 8 |
徐斐，敖虎山．盐酸右美托咪定的临床应用[J]．中国循环杂志，2015，(4)：401-403.
|
| 9 |
马立靖，马璨，李冬梅，等．预注右美托咪定的镇静效应及其对全麻患者气管插管反应的影响[J]．临床麻醉学杂志，2012，28(7)：637-639.
|
| 10 |
Okada H, Kurita T, Mochizuki T, et al.The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts[J]. Resuscitation, 2007, 74(3): 538-545.
|
| 11 |
Chi X, Liao M, Chen X, et al.Dexmedetomidine Attenuates Myocardial Injury in Off-Pump Coronary Artery Bypass Graft Surgery[J]. J Cardiothorac Vasc Anesth, 2016, 30(1): 44-50.
|
| 12 |
Kim HJ, Kim WH, Kim G, et al.A comparison among infusion of lidocaine and dexmedetomidine alone and in combination in subjects undergoing coronary artery bypass graft: a randomized trial[J]. Contemp Clin Trials, 2014, 39(2): 303-309.
|
| 13 |
Sulaiman S, Karthekeyan RB, Vakamudi M, et al.The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting[J]. Ann Card Anaesth, 2012, 15(1): 39-43.
|
| 14 |
Ibacache M, Sanchez G, Pedrozo Z, et al.Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart[J]. Biochim Biophys Acta, 2012, 1822(4): 537-545.
|
| 15 |
Schoeler M, Loetscher PD, Rossaint R, et al.Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury[J]. BMC Neurol, 2012, 12: 20.
|
| 16 |
Ge YL, Li X, Gao JU, et al.Beneficial effects of intravenous dexmedetomidine on cognitive function and cerebral injury following a carotid endarterectomy[J]. Exp Ther Med, 2016, 11(3): 1128-1134.
|
| 17 |
Rodríguez-González R, Sobrino T, Veiga S, et al.Neuroprotective effects of dexmedetomidine conditioning strategies: Evidences from an in vitro model of cerebral ischemia[J]. Life Sci, 2016, 144: 162-169.
|
| 18 |
Farag E, Argalious M, Sessler DI, et al.Use of α(2)-Agonists in Neuroanesthesia: An Overview[J]. Ochsner J, 2011, 11(1): 57-69.
|
| 19 |
Wheeler LA, Tatton NA, Elstner M, et al.Alpha-2 adrenergic receptor activation by brimonidine reduces neuronal apoptosis through AkT (protein kinase B) dependent new synthesis of BCL-2[J]. Invest Ophthalmol Vis Sci, 2001, 42(4): 411.
|
| 20 |
Engelhard K, Werner C, Eberspächer E, et al.The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(＋)-ketamine on the expression of apoptosis regulating proteins after incomplete cerebral ischemia and reperfusion in rats[J]. Anesth Analg, 2003, 96(2): 524-531.
|
| 21 |
Xue F, Zhang W, Chu HC.Assessing perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery[J]. Kidney Int, 2016, 89(5): 1164.
|
| 22 |
Karahan MA, Yalcin S, Aydogan H, et al.Curcumin and dexmedetomidine prevents oxidative stress and renal injury in hind limb ischemia/reperfusion injury in a rat model[J]. Ren Fail, 2016, 38(5): 693-698.
|
| 23 |
Taittonen MT, Kirvelä OA, Aantaa R, et al.Effect of clonidine and dexmedetomidine premedication on perioperative oxygen consumption and haemodynamic state[J]. Br J Anaesth, 1997, 78(4): 400-406.
|
| 24 |
Short J. Use of dexmedetomidine for primary sedation in a general intensive care unit[J]. Crit Care Nurse, 2010, 30(1): 29-38.
|
| 25 |
Kaygusuz K, Gokce G, Gursoy S, et al.A comparison of sedation with dexmedetomidine or propofol during shockwave lithotripsy: A randomized controlled trial[J]. Anesth Analg, 2008, 106(1): 114-119.
|
| 26 |
Ji F, Li Z, Nguyen H, et al.Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery.Circulation, 2013, 127(15): 1576-1584.
|
| 27 |
Afsani N. Clinical application of dexmedetomidine[J]. S Afr J Anaesthesiol Analg, 2010, 16(2): 50-56.
|
| 28 |
崔云凤，宋智敏，周姝，等．右美托咪定辅舒芬太尼用于全麻病人的术后镇痛[J]．中国实验诊断学，2013，17(2)：321-323.
|
| 29 |
张瑶，李伟彦．右美托咪定临床应用的研究进展[J]．医学综述，2013，19(4)：693-695.
|